RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery | MicrobiomeTrials← Back to trialsNCT05606315
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
SUSPENDEDPHASE4INTERVENTIONAL
Trial Details
Start: 2022-03-16Est. Completion: 2026-12-31
Enrollment target: 117 participants Locations- Southern medical university Nanfang hospital, Guangzhou, Guangdong, China
- Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Other microbiome trials you might be interested in
Schizophrenia DisorderSchizoaffecitve DisorderAggression
The study investigates whether a virtual reality-based mindfulness based intervention can reduce impulsive aggression in…
New York, United StatesEst. completion Jun 30, 2027
Acute Respiratory Distress Syndrome (ARDS)s100bMechanical PowerVentilator Induced Lung InjuryTranspulmonary Pressure
Acute respiratory distress syndrome (ARDS) is characterized by pathological pulmonary edema caused by direct or indirect…
Multiple LocationsEst. completion Oct 23, 2028